Vaccinex Inc VCNX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 4:00 PM EDT
7.41quote price arrow down-0.04 (-0.54%)
Volume
15,226
52 week range
7.16 - 100.80
Loading...
  • Open8.11
  • Day High8.11
  • Day Low7.29
  • Prev Close7.45
  • 52 Week High100.80
  • 52 Week High Date06/09/23
  • 52 Week Low7.16
  • 52 Week Low Date12/14/23

Key Stats

  • Market Cap8.645M
  • Shares Out1.17M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta0.74
  • YTD % Change-20.38

KEY STATS

  • Open8.11
  • Day High8.11
  • Day Low7.29
  • Prev Close7.45
  • 52 Week High100.80
  • 52 Week High Date06/09/23
  • 52 Week Low7.16
  • 52 Week Low Date12/14/23
  • Market Cap8.645M
  • Shares Out1.17M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta0.74
  • YTD % Change-20.38

RATIOS/PROFITABILITY

  • EPS (TTM)-84.04
  • P/E (TTM)-0.09
  • Fwd P/E (NTM)-6.56
  • EBITDA (TTM)-22.879M
  • ROE (TTM)-1,797.63%
  • Revenue (TTM)795,000.017
  • Gross Margin (TTM)-
  • Net Margin (TTM)-2,768.80%
  • Debt To Equity (MRQ)-3.08%

EVENTS

  • Earnings Date03/30/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Vaccinex Inc

 

Profile

MORE
Vaccinex, Inc. is a clinical-stage biotechnology company. It discovers and develops targeted biotherapeutics to treat diseases with unmet medical needs, including cancer, neurodegenerative diseases and autoimmune disorders. Its platform technologies include SEMA4D antibody platform and ActivMAb antibody discovery platform. SEMA4D antibody platform is the application of its knowledge of SEMA4D biology to develop its lead product candidate pepinemab for the treatment of various...
Albert Friedberg
Chairman of the Board
Maurice Zauderer Ph.D.
President, Chief Executive Officer, Director
Elizabeth Evans Ph.D.
Chief Operating Officer, Senior Vice President - Discovery and Translational Medicine
Jill Sanchez
Interim Chief Financial Officer
Address
1895 Mount Hope Ave
Rochester, NY
14620-4540
United States

Top Peers

SYMBOLLASTCHG%CHG
CANF
Can Fite Biopharma Ltd
2.22-0.04-1.77%
LGVN
Longeveron Inc
3.25+0.14+4.50%
BCDA
BioCardia Inc
0.407-0.0121-2.8871%
GRTX
Galera Therapeutics Inc
0.14-0.0135-8.7948%
NTBL
Notable Labs Ltd
1.77-0.03-1.67%